Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03569020 · ClinicalTrials.gov registry record · NA

The Diet Gout Trial

A NA study of Gout and Hyperuricemia, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
43
Enrollment target
2
Study locations

NCT03569020 is a NA study of Gout and Hyperuricemia that has completed, run by Johns Hopkins University. The registered enrollment target is 43 participants, below the 8,887-participant average among 34 other Gout trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03569020, a NA study of Gout and Hyperuricemia, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target
2
Study locations

Study Summary

Unhealthy diet has long been associated with high uric acid levels and gout. The DASH diet may lower uric acid levels. This study will examine the effects of the DASH diet on uric acid in adults with a history of gout.

Conditions Studied

Interventions

  • OTHER Subsidy for food purchases and dietitian education

Study Locations (2)

Maryland

  • Johns Hopkins ProHealth Research Clinic - Woodlawn

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2018-08-07
Est. Completion 2019-07-23
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT03569020

The ClinicalTrials.gov registry entry for NCT03569020 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 8,887-participant average among 34 other Gout trials with a reported enrollment target (100% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Gout appearing as the primary indexed condition, and to 1 intervention - of which Subsidy for food purchases and dietitian education is the first listed.

NCT03569020 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03569020 about?

NCT03569020 is a clinical study titled "The Diet Gout Trial". Unhealthy diet has long been associated with high uric acid levels and gout. The DASH diet may lower uric acid levels. This study will examine the effects of the DASH diet on uric acid in adults with a history of gout.

What is the current status of trial NCT03569020?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2018-08-07. Estimated completion is 2019-07-23.

What conditions does trial NCT03569020 study?

This clinical trial studies the following conditions: Gout, Hyperuricemia.

What interventions are being tested in trial NCT03569020?

The interventions under investigation include: Subsidy for food purchases and dietitian education (OTHER).

Who is sponsoring clinical trial NCT03569020?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03569020 being conducted?

This trial has 2 study locations across Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gout

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.